Doctors anticipate patient requests for experimental remdesivir before all the evidence comes in

An ICU staff member cares for a COVID-19 patient at St. Joseph’s Hospital in Yonkers, N.Y.
John Minchillo/AP

Date of Publication: April 30, 2020

Source: Stat News

On Wednesday, preliminary data from a randomized controlled trial by the National Institute of Allergy and Infectious Disease revealed promising results for remdesivir in speeding up recovery in hospitalized COVID-19 patients. Doctors are anticipating more requests for access to the drug from patients and families in the coming days. While the results are promising, the drug is still experimental, not widely available, and has not yet been approved for emergency use. Doctors on the frontlines are optimistic but note the importance of additional research and clinical trials. Unanswered questions remain on the effectiveness of remdesivir in less ill patients and whether it has a role to play in disease prevention.

Read the full article here:

Summary by: Angus Lau